BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15882871)

  • 1. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol.
    Schiller D; Zuckerman L; Weiner I
    J Psychiatr Res; 2006 Mar; 40(2):167-77. PubMed ID: 15882871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesions to the basolateral amygdala and the orbitofrontal cortex but not to the medial prefrontal cortex produce an abnormally persistent latent inhibition in rats.
    Schiller D; Weiner I
    Neuroscience; 2004; 128(1):15-25. PubMed ID: 15450350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.
    Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):257-97. PubMed ID: 12601500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment.
    Weiner I; Arad M
    Behav Brain Res; 2009 Dec; 204(2):369-86. PubMed ID: 19433114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
    Barak S; Weiner I
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.
    Zuckerman L; Rimmerman N; Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):298-307. PubMed ID: 12827344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats.
    Arad M; Weiner I
    Psychoneuroendocrinology; 2012 Feb; 37(2):200-12. PubMed ID: 21723667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs.
    Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ
    Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift.
    Schiller D; Weiner I
    Behav Brain Res; 2005 Aug; 163(1):115-21. PubMed ID: 15921766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluctuation of latent inhibition along the estrous cycle in the rat: modeling the cyclicity of symptoms in schizophrenic women?
    Arad M; Weiner I
    Psychoneuroendocrinology; 2008 Nov; 33(10):1401-10. PubMed ID: 18819755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex.
    Uehara T; Sumiyoshi T; Matsuoka T; Itoh H; Kurachi M
    Synapse; 2007 Jun; 61(6):391-400. PubMed ID: 17372984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect.
    Gal G; Schiller D; Weiner I
    Behav Brain Res; 2005 Jul; 162(2):246-55. PubMed ID: 15970218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats.
    Morrow BA; Rosenberg SJ; Roth RH
    Synapse; 1999 Oct; 34(1):28-35. PubMed ID: 10459169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.
    Shadach E; Gaisler I; Schiller D; Weiner I
    Neuropsychopharmacology; 2000 Aug; 23(2):151-61. PubMed ID: 10882841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
    Weiner I; Schiller D; Gaisler-Salomon I
    Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.
    Gaisler-Salomon I; Diamant L; Rubin C; Weiner I
    Psychopharmacology (Berl); 2008 Feb; 196(2):255-67. PubMed ID: 17928997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR).
    Santoro ML; Ota VK; Stilhano RS; Silva PN; Santos CM; Diana MC; Gadelha A; Bressan RA; Melaragno MI; Han SW; AbĂ­lio VC; Belangero SI
    Schizophr Res; 2014 Aug; 157(1-3):163-8. PubMed ID: 24893910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.